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1. Introduction 
Squalene poxidation and cyclisation are steps of 
cholesterol biosynthesis which result in conversion of 
squatene to lanosterol. We could demonstrate [ 1] that 
human placenta possesses an effective epoxidase cy- 
clase activity which leads under our experimental con- 
ditions to lanosterol rather than to cholesterol; however 
this epoxidase cyclase has a low basal evel. More recent- 
ly we located the rate limiting step in the epoxidation 
process [2] . 
The placental epoxidase activity is highly increased 
[l] by addition of liver squalene carrier protein (SCP). 
Thus, the low basal epoxidase activity of placental mi- 
crosomes could be related to a lack of SCP or to an al- 
teration of the squalene binding capacity of the placental 
cytosol proteins. The aim of this work is to look for 
these two possibilities. 
The squalene binding capacities of native and heated 
human placental 105 000 g supernatant (S 105), of na- 
tive and heated rat liver S 105, bovine serum albumin 
and human plasma proteins were studied by Sephadex 
gel filtration. The binding capacity of these fractions was 
compared to their ability to activate microsomal squale- 
ne epoxidase. It is shown that native placental S 105 
has an important squalene binding capacity but is not 
very efficient in activating liver or placental epoxidase. 
Thus, at least in placenta, the squalene binding and the 
epoxidase activation.should be related to different fac- 
tors. 
2. Materials and methods 
2.1, Microsomes and S 105 of rat liver and human pla- 
ten ta 
Fresh human placentas are hashed (meat grinder) and 
washed with ice-cold 0.02 M phosphate buffer, pH 7.35, 
0.001 M EDTA (buffer A), to remove blood prior to 
homogen~ation. After centrifugation (13 000 g, 20 min), 
the pellet is homogenized (Ultra Turrax) in buffer A and 
microsomes and S 105 are separated by differential ul- 
tracentrifugation as previously described [ 11, except 
that we carried out an additional washing of microsomes 
with buffer A. Protein concentration was determined by 
the spectrophotometric method of KaIckar [3] or the 
calorimetric method of Lowry [4]. 
2.2. Conversion of squalene to lanosterol 
In a final volume of 10 ml (buffer A) 40 mg of mi- 
crosomal proteins were incubated uring 2 10 min at 
37°C under oxygen, with 25 mg of placental S 105 
proteins or the same amount of bovine serum albumin 
or rat liver S 105 proteins. Cofactors and squalene were 
present in the following concentrations: NAD, NADPH 
(Boehringer): 0.4 mM; reduced glutathione (Boehringer): 
5mM;Mg”: 3X 10~2M;[ll,123H]sequalene(18mCi/ 
mM): 0.45 X 10m6 M (total radioactivity: 180 000 dpm). 
Other conditions and the procedure used to dissolve 
squalene have been described in detail [l] . The isolation 
of reaction products was slightly modified as described 
earlier [2]. The results are expressed as percent of con- 
version of squalene to lanosterol [l] . 
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2.3. Studies on squalene binding 
2.3.1. Gel filtration of G25 Sephadex 
30 ~1 of a squalene solution in hexane (180 000 dpm) 
are evaporated to dryness in the incubation vial and dis- 
solved in 20 ti of dioxane-glycol(211 : v/v). This solu- 
tion is diluted in 2.5 ml of S 105 and the radioactivity of 
two 0.1 ml aliquots is determined by liquid scintillation 
counting in 15 ml of scintillator 1 (toluene/PPO/POPOP: 1 
liter/l g/O.1 g). Two ml of squalene solution in S 105 
are incubated (37QC, 15 min) and applied to a G 25 ‘se- 
phadex column (2 X 30 cm). The elution is processed at 
4°C with buffer A (at a rate of 1 ml/min). The protein 
bound radioactivity is determined by liquid scintillation 
counting of 0.2 mf aliquots in 3 ml ethanol t 12 ml of 
scintillator 1. 
Controls are performed in the same conditions with 
buffer A instead of S 105. 
It must be pointed out that dioxane should be freshly 
distilled because peroxidized ioxane abolishes the bin- 
ding of both placental and liver S 105, probably by pro- 
tein inactivation. The non protein bound squalene (free 
squalene) isadsorbed on the G25 Sephadex column, and 
accumulates a  chromatographies are repeated; control 
experiments have shown that this column should not 
be used more than twice. 
2.3.2. Gel filtration on G 200 Sephadex 
Place&I S 105 protein (20 mg) are filtered on a G 
200 Sephadex column (2 X 65 cm). Fractions contain- 
ing proteins of molecular weight lower than 100 000 
are concentrated (Carbowax), incubated (37’C, 15 min) 
with [ 11 ,12-3H] squalene (1.1 X 10m6 M) and filtered 
again on the same column. 
2.3.3. Electrophoresis 
Electrophoresis on cellulose acetate was done with 
‘Cellogel’ Chemetron, in the conditions described by the 
manufacturer. For liquid scintillation counting, the 
strips are cut and counted after elution of squalene in 
a mixture Triton X 100 and scintillator 1 (1/2:v/v). 
Polyacrylamide gel electrophoresis was performed 
with S 105 preincubated (or not) with radioactive squ- 
aIene (incubation conditions of 2.3.1.), according to 
the method of Weber_[S] . The gel were cut and the 
fragments digested in NCS (Amersham) (1 ml, 15 min, 
6O*C) before count~g. 
2.3.4. Dextran coated charcoal technique 
Conditions are similar to those used by Mercier [6] 
for the study of steroid binding by plasma proteins: 
S 105 proteins pre~cubated in the con~tions des- 
cribedabove(2.3.1)with [ll,12-3H] squalene(l.8X 
lOa M) were stirred with an equal volume of a dex- 
tran coated charcoal suspension i buffer A (Norit Pro- 
labo: 0.5 g/l00 ml; Dextran T 70 Pharmacia: 0.05 
g/100 ml). Aliquots are taken at 0, 15,40,60 min 
and centrifuged (4000 rpm X 20 min). The radioac- 
tivity of the supernatant isdetermined by liquid scin- 
tillation counting as in 2.3.1. 
3. Results and discussion 
3.1. Effect of placental 105 000 g supematant on mi- 
crosomal squalene to lanosterol conversion 
Table 1 shows the results of a serie of incubations. 
The conversion of squalene to lanosterol by washed 
placental microsomes i activated (2 or 3 times) by na- 
tive placental S 105, but not by heated placental S 105 
or bovine serum albumin. However, a higher activation 
is observed when placental microsomes are incubated 
in the presence of rat liver S 105. 
A placental lack in SCP could explain the different 
abilities of placental S 105 and of hepatic S 105 to ac- 
tivate microsomal conversion of squalene into lanoste- 
rol. Thus we looked for the presence of a squalene bind- 
ing protein in placental S 1 OS. 
3.2. Squalene binding capacity of placental S 105 
Since equ~ibrium dialysis was ~adequate to study 
this binding (in the conditions used, squalene is not dia- 
Table 1 
Squalene to lanosterol conversion by washed 
placental microsomes 
Incubation medium Conversion 
(%) 
Buffer A 0.5 (2) 
Native placental S 105 1.4-1.9 (3) 
Heated placental S 105 0.4 (1) 
Native rat liver S 105 3.6-5.3 (2) 
Bovine serum albumin 0.9 (1) 
The number of experiments is indicated in brackets. 
67 
Volume 47, number 1 FEBS LETTERS October 1974 
Table 2 
Squ&ne binding by native placental 105 000 g supernatant studied by gel filtration on G 25 Sephadex column 
Sample applied to the column 
Proteins 
(mg) 
Radioactivity 
(dmp X 10e3) 
Character&es of V, * effluent 
Radioactivity Radioactivity/mg 
(dpm x IO-‘) of proteins 
(dpm X IO-‘/mg) 
Protein bound 
SquaIene 
(ng/mg protein) 
Control: Buffer A 
Fresh native placental 
s 105 
(Sample 1) 
Sample 1 after 
two months storage 
at -20°c 
Fresh native piacen- 
tal SlOS(Sample 2) 
0 
12 
6 
3 
1.2 
0.3 
0.15 
1.2 
0.3 
915 
1.9 
0.95 
0.475 
120 
136 
170 
113 
48 
2s 
58 
42 
145 
96 
97 
80 
0 0 0 
115 9 90 
111 19 180 
122 40 380 
48 40 380 
11 39 370 
5 39 370 
8 7 70 
3 11 106 
89 9 88 
66 -34 324 
27 29 280 
13 29 280 
* v, = Exclusion volume, determined by blue dextran filtration. 
lysable), we used the method of gel filtration of G 25 
Sephadex columns. 
Table 2 shows that after incubation with native pla- 
cental S 105, radioactive squalene is partly eluted with 
the proteins in the exclusion volume, free squalene be- 
ing completely adsorbed on the column, as shown by 
the results obtained with buffer alone. 
The binding of squalene to S 105 placental proteins 
can also be shown by the incubation in the presence of 
dextran coated charcoal (fig. 1) as described in 2.3.4.: 
after a 60 min dextran charcoal treatment, more than 
8.5 per cent of [ 11 ,I 2i3H] squalene remains in the su- 
pernatant, bound to the placental S 105 proteins, where- 
as in the absence of placental S 105,86 per cent is 
adsorbed on charcoal. 
As the squalene concentration could be neither in- 
creased (because of its low solubility) nor decreased 
(because of its low specific activity), the saturation of 
the protein binding could be studied only by varying 
the protein concentration and an eventual high affini- 
ty and specific binding (Kd G IO-’ M) could not be 
tested. Table 2 shows that when 1.8 X 10e6 M squalene 
is incubated in the presence of decreasing amounts of 
native placental S 105, a ‘saturation’ is observed with 
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the binding of about 1 nmole of squalene per mg pro- 
tein. The binding capacity of placental S 105 is decreas- 
ed after a 2 months storage at -20°C. 
Table 3 shows that the ‘saturation’ of the S 10.5 is 
not observed with heated placental S 105. S~ilarly, in 
Rqdloactlve squoleno in the 
supeinotant I dpm x 10 -’ 1 
t 
IO 1 placenta ““~______________0___ _..._ _o 
5 
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Fig. 1. Squaiene binding to proteins of native placental 105 000 
g supernatant. After preincubation (37”C, 15 min) of [ 11 ,12-’ H] 
squalene with native placental 105 000 g supernatant, free squa- 
lene is adsorbed by dextran charcoal treatment, separated by 
centrifugation and the radioactivity of the supernatant (protein 
bound squalene) determined by liquid scintillation counting. For 
expe~ment~ details and references ee text (2.3.1. and 2.3.4.). 
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Table 3 
Squ~ene binding by heated placental 1 OS 000 g supernatant studied by gel filtration on G 25 Sephadex c&mn 
Sample applied to the column 
Proteins 
kg) 
Radioactivity 
(DPM X lo-‘) ’ 
Characteristics of V, * effluent 
~~oactivity/mg 
Radioactivity of proteins 
(DPM X 10-j) (DPM X lo-“/mg) 
Protein bound 
Squalene 
(nglmg protein) 
Sample 1 
Sample 1 
after two months 
storage at -20°C 
1.2 142 110 91 870 
0.6 141 106 177 1670 
0.3 130 99 330 3137 
0.12 142 86 719 6838 
0.06 108 76 1270 12065 
0.03 93 39 1300 12354 
0.015 54 29 1900 18050 
0.12 76 56 474 4500 
0.06 75 43 717 6905 
0.024 7.5 30 1270 12000 
* V, = Exclusion volume, determined by blue dextran filtration. 
Table 4 
Squalene binding by native rat liver 105 OOOg supernatant studied by gel filtration on G 25 Sephadex column 
Sample applied to the column 
Proteins 
(mg) 
Radioactivity 
(DPM X lo-“) 
Characteristics of V, * effluent 
Radioactivity Radioactivity/mg 
(DPM X lo-‘) of proteins 
(DPM X lo-‘/mg) 
Protein bound 
Squalene 
(ng/mg protein) 
Fresh native 
rat liver S 10.5 30 120 88 2935 28 
12 109 64 5330 51 
6 111 55 9188 81 
3 95 47 15690 149 
0.6 94 12 20700 196 
0.3 78 9 31840 302 
0.2 106 67 336250 3194 
0.15 100 75 502060 4769 
* V, = Exclusion volume, determined by blue dextran filtration. 
the same conditions, human plasma proteins, native and not be related to the presence of serum ~burn~ or Ii- 
heated bovine serum atbumin (BSA}, native and heated poproteins, since the hemo~obin dete~inations have 
rat liver S 105, also bind squalene but the binding does shown this contamination to be less than l-2%. Fur- 
not seem to be limited. Table 4 shows as an example the thermore, on cellogel electrophoresis, there is no squalene 
results obtained with native rat liver S 105. binding protein in the albumin zone. 
The absence of sa~ration observed both with native 
and heated rat liver S 10.5 can be related to the presence 
of several proteins able to bind this molecule: SCP (7,8] 
serum albumin, ljpoproteins, the two latter being able 
to give ‘non-specific’, non-sa~rab~e squalene bin~g. 
However, in placental S 105, the squalene binding can- 
3.3, Squaiene induced aggregation of the placentai ‘SCP 
Iske’proteins 
We looked for such an a~regation since Scallen [8,9] 
and Ritter IlO] reported that rat liver SCP has a low 
molecular weight (< 100 000) and aggregates in the pre- 
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Fig. 2a: G 200 Sephadex fdtration of native placental 105 OOOg supernatant. Fig. 2b: G 200 Sephadex filtration of proteins of 
peak 2 (from fig. 2a) after preincubation with tritiated squalene. 
sence of squalene. 
When the placental S 105 is filtered on a G 200 
Sephadex column, three peaks of proteins are eluted 
contain the SCP (mol. wt. < 100 ~0)) after concentra- 
contain the SCP (mol. wt. < 100 000) after concentra- 
tion and incubation in the presence of labelled squalene, 
are fitered on the same Sephadex G 200 column. The 
fig. 2b shows that a squelene binding protein appears in 
the exclusion volume (speak A, mol. wt. > 200 000). 
This new fraction accounts for only a small part of the 
proteins of peak 2; the main part (peak B) being eiuted 
in the same volume as formerly. If proteins of peak 2 
are not incubated with squalene, they are eluted in 
their former elution volume, showing that aggregation 
is not related to the concentration procedure. 
This aggregation is also confirmed by polyacrylami- 
de gel disc electrophoresis performed on placental or 
rat liver S 105 preincubated in the presence of labelled 
squalene. In both cases, the squalene binding proteins 
are excluded from the gel (7% acrylamide concentra- 
tion). 
Conclusions 
Our results how that placental S 105 has a true squ- 
alene binding capacity, but is not very efficient in acti- 
vating liver or placental squalene poxidase [ 21. This 
latter observation could be explained by the limited bin- 
ding capacity of placental S 105 with regards to the un- 
limited binding capacity of rat liver S 105. But we show 
that heated rat liver S 105 or native serum albumin, 
which have also an unlimited squalene binding capacity, 
does not activate squalene poxidase. Thus there is no 
correlation between total squalene binding capacity of 
S 105 as measured till now by ourselves or others, and 
squalene poxidase activation. Our results do not rule 
out the presence of a true SCP in the human placental 
S 105 but, as Bloch suggested for the liver [I If , in the 
placenta, the binding capacity and the epoxidase activa- 
tion should be related to different protein factors or two 
different functions of a same protein. 
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